102 related articles for article (PubMed ID: 7624388)
1. Successful treatment with flupenthixol decanoate of a patient with both schizophrenia and alcoholism.
Soyka M; Sand P
Pharmacopsychiatry; 1995 Mar; 28(2):64-5. PubMed ID: 7624388
[TBL] [Abstract][Full Text] [Related]
2. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
Potvin S; Stip E; Roy JY
Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
[TBL] [Abstract][Full Text] [Related]
3. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Kong DS; Yeo SH
Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
[TBL] [Abstract][Full Text] [Related]
4. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 1. Alcoholism and schizophrenia].
Soyka M
Fortschr Neurol Psychiatr; 1994 Mar; 62(3):71-87. PubMed ID: 8181788
[TBL] [Abstract][Full Text] [Related]
5. Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.
Schmidt K; Nolte-Zenker B; Patzer J; Bauer M; Schmidt LG; Heinz A
Pharmacopsychiatry; 2001 Mar; 34(2):66-72. PubMed ID: 11302566
[TBL] [Abstract][Full Text] [Related]
6. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].
Soyka M
Fortschr Neurol Psychiatr; 1994 Jun; 62(6):186-96. PubMed ID: 8050773
[TBL] [Abstract][Full Text] [Related]
7. Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study.
Levin FR; Evans SM; Coomaraswammy S; Collins ED; Regent N; Kleber HD
Am J Drug Alcohol Abuse; 1998 Aug; 24(3):343-60. PubMed ID: 9741939
[TBL] [Abstract][Full Text] [Related]
8. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
[TBL] [Abstract][Full Text] [Related]
9. Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study.
Soyka M; Aichmüller C; v Bardeleben U; Beneke M; Glaser T; Hornung-Knobel S; Wegner U
Eur Addict Res; 2003 Apr; 9(2):65-72. PubMed ID: 12644732
[TBL] [Abstract][Full Text] [Related]
10. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
Green AI
J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
[TBL] [Abstract][Full Text] [Related]
11. [Positive and negative symptoms in chronic schizophrenic patients under maintenance therapy with flupenthixol decanoate for a twelve month perioid].
Pach J; Finkbeiner T; Glaser T; Haug J; Osterheider M; Tegeler J
Fortschr Neurol Psychiatr; 1998 Oct; 66(10):442-9. PubMed ID: 9825249
[TBL] [Abstract][Full Text] [Related]
12. Behavioral interventions for dual-diagnosis patients.
Goldsmith RJ; Garlapati V
Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
[TBL] [Abstract][Full Text] [Related]
13. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
14. [Alcohol and drug abuse as risk factors for violence and delinquency in schizophrenic patients].
Soyka M; Immler B; Sand P
Psychiatr Prax; 1993 Sep; 20(5):172-5. PubMed ID: 8248441
[TBL] [Abstract][Full Text] [Related]
15. Anhedonia in schizophrenic, depressed, or alcohol-dependent patients--neurobiological correlates.
Heinz A; Schmidt LG; Reischies FM
Pharmacopsychiatry; 1994 Jul; 27 Suppl 1():7-10. PubMed ID: 7984706
[TBL] [Abstract][Full Text] [Related]
16. [Total illness costs of schizophrenia and monetary evaluation of prevention of recurrence exemplified by a standard depot neuroleptic (flupenthixol decanoate)].
Osterheider M; Franken-Hiep K; Horn R
Psychiatr Prax; 1998 Jan; 25(1):38-43. PubMed ID: 9530768
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of schizophrenia patients with comorbid substance abuse.
Wilkins JN
Schizophr Bull; 1997; 23(2):215-28. PubMed ID: 9165632
[TBL] [Abstract][Full Text] [Related]
18. [Incidence of the deficit form in refractory schizophrenia].
Samuelian JC
Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
[TBL] [Abstract][Full Text] [Related]
19. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
[TBL] [Abstract][Full Text] [Related]
20. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia.
Hamera E; Schneider JK; Deviney S
J Nerv Ment Dis; 1995 Sep; 183(9):559-65. PubMed ID: 7561817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
